|
gptkbp:instanceOf
|
gptkb:UK_Supreme_Court_case
|
|
gptkbp:application
|
gptkb:Warner-Lambert_Company_LLC
|
|
gptkbp:citation
|
gptkb:[2019]_1_All_ER_161
gptkb:[2019]_RPC_6
|
|
gptkbp:country
|
gptkb:United_Kingdom
|
|
gptkbp:date
|
2018-11-14
|
|
gptkbp:fullName
|
gptkb:Warner-Lambert_Company_LLC_v_Generics_(UK)_Ltd_t/a_Mylan_and_another
|
|
gptkbp:judge
|
gptkb:Lord_Mance
gptkb:Supreme_Court_of_the_United_Kingdom
gptkb:Lord_Sumption
gptkb:Lord_Reed
gptkb:Lord_Briggs
gptkb:Lord_Hodge
|
|
gptkbp:legalIssue
|
sufficiency of disclosure
infringement of second medical use patents
|
|
gptkbp:legalSubject
|
gptkb:US_patent
pharmaceutical patents
|
|
gptkbp:neutralCitation
|
gptkb:[2018]_UKSC_49
|
|
gptkbp:response
|
gptkb:Actavis_Group_PTC_EHF
gptkb:Generics_(UK)_Ltd_t/a_Mylan
|
|
gptkbp:bfsParent
|
gptkb:Lee_v._Ashers_Baking_Company_Ltd
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
[2018] UKSC 49
|